Product Information
AMOX-CLAV 875-125 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $0.2856 per EA under NDC 00143924920. Its NADAC has been published 472 times since Aug 9, 2017.
FDA first approved this application on Aug 23, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
875; 125 mg/1; mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00143924920
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMOXICILLIN; CLAVULANATE POTASSIUMApproval Type
Generic (ANDA)
FDA Application
ANDA203824FDA Approved
8/23/2016
TE Code
AB
On Market Since
8/23/2016
Pharmacological Classes
Price Statistics
The NADAC for AMOX-CLAV 875-125 MG TABLET has been published 472 times since Aug 9, 2017, and over the history we have for it it has declined 26.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2856 per EA |
|---|---|
| All-time high | $0.4414 (Jan 10, 2018) |
| All-time low | $0.2631 (Nov 20, 2024) |
| 52-week high | $0.3080 |
| 52-week low | $0.2711 |
| Median price | $0.3086 |
| Average price | $0.3173 |
| Largest weekly change | -26.7% (Jul 22, 2020) |
| Weeks tracked | 472 |
| Tracking since | Aug 9, 2017 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMOX-CLAV 875-125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for AMOX-CLAV 875-125 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $0.2856 per EA (NDC 00143924920), effective Aug 19, 2026.
How has the price of AMOX-CLAV 875-125 MG TABLET changed over time?
Over the history we have for it, the NADAC for AMOX-CLAV 875-125 MG TABLET has declined 26.1%. It has been tracked across 472 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for AMOX-CLAV 875-125 MG TABLET?
Since Aug 9, 2017, the NADAC for AMOX-CLAV 875-125 MG TABLET has ranged from a low of $0.2631 (Nov 20, 2024) to a high of $0.4414 (Jan 10, 2018), with a median of $0.3086 per EA.
Are there cheaper alternatives to AMOX-CLAV 875-125 MG TABLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, AMOX-CLAV 875-125 MG TABLET, is $0.2711 per EA — about 5% below AMOX-CLAV 875-125 MG TABLET.
Who manufactures AMOX-CLAV 875-125 MG TABLET?
AMOX-CLAV 875-125 MG TABLET (NDC 00143924920) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.